Baby - Mom > Hospital

Decreases in Nephrotoxic Pain Medications Are Not Associated With Increased Opioid Utilization in Critically Ill Children

2 monthes ago   |   By Pediatric Critical Care Medicine

Objectives:
Quality improvement initiatives to decrease rates of nephrotoxic medication exposure have reduced rates of acute kidney injury in noncritically ill children. The objective of our study was to analyze the implementation of a similar program in critically ill children and to measure important balancing measures including opioid and benzodiazepine exposure.
Design:
Prospective quality improvement study.
Setting:
PICU at Children's Hospital Colorado between 2018 and 2020.
Patients:
All children admitted to PICU.
Interventions:
Quality improvement initiative called Nephrotoxic...
Read more ...

 


Search by Tags

   Hospital      Drugs      Online Clinical Investigation  


Healthy plant-based diets linked to lower colorectal cancer risk in men

Healthy plant-based diets linked to lower colorectal cancer risk in men

Diets high in healthy plant foods and low in unhealthy plant foods were associated with a lower colorectal cancer risk in men, a recent study published in BMC Medicine... Read more ...

CGM use lowers hospitalizations, may reduce mortality in type 1 and type 2...

CGM use lowers hospitalizations, may reduce mortality in type 1 and type 2 diabetes

Use of continuous glucose monitoring was associated with a lower risk for all-cause hospitalization and mortality in adults with type 1 and type 2 diabetes attending Veterans... Read more ...

Strep A child deaths grow to FIVE

Strep A child deaths grow to FIVE

Cases of bacterial infection Strep A are nearly five times higher among young children than pre-pandemic, health officials have confirmed in the wake of five deaths. Read more ...

First patient treated in study of neuromodulation device for Lennox-Gastaut...

First patient treated in study of neuromodulation device for Lennox-Gastaut Syndrome

NeuroPace Inc. announced that the first patient with Lennox-Gastaut Syndrome was treated in its investigational device exemption feasibility study, which will evaluate the... Read more ...

‘Can't be in 10 places at once': Social media now a key part of rheumatology...

‘Can't be in 10 places at once': Social media now a key part of rheumatology meetings

COVID-19 was in so many ways an inflection point for nearly all aspects of health care, with one of the most conspicuous, continuing examples of “pre-2020” differing from... Read more ...

Prince William And Kate Middleton Met An Adorable Costumed 8-Year-Old Fan

Prince William And Kate Middleton Met An Adorable Costumed 8-Year-Old Fan

Prince William and Kate Middleton are in the United States for the first time since 2014. The newly titled Prince and Princess of Wales are in Boston, Massachusetts, this week... Read more ...

Adam Sandler's Teen Daughters Wrote His Self-Roasting Gotham Award Speech

Adam Sandler's Teen Daughters Wrote His Self-Roasting Gotham Award Speech

Even though Adam Sandler's two teenage daughters , Sunny, 14, and Sadie, 16, were not in New York City with their dad for the Gotham Awards, they managed to have the award... Read more ...

Insulin resistance, hyperinsulinemia primary drivers of atherosclerotic CVD

Insulin resistance, hyperinsulinemia primary drivers of atherosclerotic CVD

Underlying insulin resistance and hyperinsulinemia work together as “bad actors” to drive atherosclerotic CVD long before a person is diagnosed with type 2 diabetes, and early... Read more ...

Buprenorphine may be safer than methadone for opioid use disorder in pregnancy

Buprenorphine may be safer than methadone for opioid use disorder in pregnancy

New data published in The New England Journal of Medicine showed that buprenorphine use during pregnancy was associated with a lower risk for adverse neonatal outcomes compared... Read more ...

Positive results announced from phase 2 trial of oral MS therapeutic

Positive results announced from phase 2 trial of oral MS therapeutic

Clinical-stage biopharmaceutical company Clene Inc. announced proof-of-concept evidence of potential neuroprotective effects of CNM-Au8, an oral therapeutic for patients with... Read more ...